Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > No earnings call, only presentation.
View:
Post by Lemoyne on Nov 11, 2024 7:08am

No earnings call, only presentation.

This is either turning into a dumpster fire or going private.
Comment by QContinuum1 on Nov 11, 2024 8:12am
I'm betting on the former. I think topline is going to be awful and as a result bottom line got measurably worse.  They naturally don't want to speak to it because that would be just hard and maybe they already know there isn't any analyst interest so why bother. The more I think about it, especially in combo with Strachan's new venture, the more I think it was an ouster and ...more  
Comment by Lemoyne on Nov 11, 2024 9:58am
As stated by other people, they have done cc even when revenues dropped from 40+M/Q to
Comment by Lemoyne on Nov 11, 2024 10:02am
QC, what will you make of it if Q3 has positive EBITDA?
Comment by Lvlchange on Nov 11, 2024 10:19am
Too many rumours. 
Comment by QContinuum1 on Nov 11, 2024 10:42am
They were within a breath of it last Q, so what I make of it is much ado about nothing.  If topline has flatlined, then breakeven doesn't move the SP needle apart from confirming that the cash runway is a bit longer which has been long priced in IMO. I'd be happy with an equity stake from a big player (say pharma) or a takeout >$1.  Anything other than that, I won't be ...more  
Comment by Lvlchange on Nov 11, 2024 12:19pm
https://www.investopedia.com/terms/e/earnings-call.asp
Comment by Lemoyne on Nov 11, 2024 12:48pm
What I meant was: How do you interpret LABS cancelling cc if earnings are ok/ good. The reason you state they might of canceled cc is negative earnings report. What if EBITDA and other measures stay flat or trend positively?
Comment by QContinuum1 on Nov 11, 2024 12:53pm
Understood, and ya, I'm a wet blanket, so I don't see it positively.  Flat topline isn't positive to me, not with international markets frothing, and bottom line neutral (plus or minus zero by a hair) also isn't positive for me. That said, if they do surprise and the income statement shows significant positivity from top to bottom, then I grant you, canceling the call would ...more  
Comment by alleyesonme on Nov 11, 2024 9:42am
They've always held a CC even when the numbers were disastrous...IMO big news pending...buyout or merger IMO...purchaser wants hope facility included..dropping the News before or on Thursday..speculation..but something is up..going to be an interesting week.  
Comment by subaru1 on Nov 12, 2024 5:03pm
These CC were useless, they were putting in words what they wrote in the qrt release so what. As usual here there is speculation based again nothing, just pure speculation of a buy out or an acquisition, these are absolutly no raison to cancel a CC.  If the revenue exceed $11,5 millions for the 3 qrt it will be good, we might be surprise and may be not on the good side. We will find out in ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities